Skip to main content
Premium Trial:

Request an Annual Quote

Talis Biomedical: Melissa Gilliam

Talis Biomedical, a developer of molecular point-of-care infectious disease diagnostic tests, has appointed Melissa Gilliam to its board of directors. Gilliam is the Ellen H. Block Professor of Health Justice and vice provost of the University of Chicago. She is also a professor of obstetric and gynecology and professor of pediatrics at the university, and is the founder and director of the Center for Interdisciplinary Inquiry and Innovation in Sexual and Reproductive Health. Gilliam holds a BA in English from Yale University, an MA in philosophy and politics from Oxford University, an MD from Harvard Medical School, and an MPH in epidemiology and biostatistics from the University of Illinois at Chicago. She completed her residency in obstetrics and gynecology at Northwestern University.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.